Old Web
English
Sign In
Acemap
>
authorDetail
>
Greg Motz
Greg Motz
Medicine
Cancer research
CD20
Immunology
Chimeric antigen receptor
3
Papers
4
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preliminary Clinical Results of a Phase 1 Study Evaluating the Safety and Anti-Tumor Activity of ACTR707 in Combination with Rituximab in Subjects with Relapsed or Refractory CD20+ B-Cell Lymphoma
2018
Blood
Ian W. Flinn
Jonathon B. Cohen
Luke P. Akard
Samantha Jaglowski
Michael J Vasconcelles
Ann Ranger
Patricia L. Harris
Francis Payumo
Greg Motz
Veronika Bachanova
Show All
Source
Cite
Save
Citations (2)
Adaptability of Antibody-Coupled T Cell Receptor (ACTR) Engineered Autologous T Cells in Combination with Daratumumab over CAR-Based Approaches
2017
Blood
Taylor Hickman
Adrianna Graziano
Katie OCallaghan
Ryan Boomer
Eugene Choi
Allison Nelson
Greg Motz
Jessica Sachs
Birgit Schultes
Seth Ettenberg
Tooba A. Cheema
Show All
Source
Cite
Save
Citations (2)
Actr Platform As an Adaptable, Universal T Cell Therapy That Can Target Multiple Tumor Antigens to Overcome Antigen Escape
2016
Blood
Greg Motz
Eugene Choi
Tooba Cheema
Taylor Friedman
Taylor Hickman
Allison Nelson
John Shin
Ryan Boomer
James Hemphill
Kathleen E. McGinness
Heather Huet
Seth Ettenberg
Show All
Source
Cite
Save
Citations (0)
1